# A Trial Investigating the Continuous Subcutaneous Insulin Infusion of a Liquid Formulation of BioChaperone Insulin Lispro in Comparison to Humalog®

> **NCT02562313** · PHASE1 · COMPLETED · sponsor: **Adocia** · enrollment: 80 (actual)

## Conditions studied

- Type 1 Diabetes Mellitus

## Interventions

- **DRUG:** BioChaperone insulin lispro
- **DRUG:** Humalog®

## Key facts

- **NCT ID:** NCT02562313
- **Lead sponsor:** Adocia
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-09
- **Primary completion:** 2016-11
- **Final completion:** 2016-11
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2016-11-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02562313

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02562313, "A Trial Investigating the Continuous Subcutaneous Insulin Infusion of a Liquid Formulation of BioChaperone Insulin Lispro in Comparison to Humalog®". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02562313. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*